Subject
Health Policy,Oncology,Internal Medicine
Reference5 articles.
1. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial;Sapoval;Lancet Reg Health Eur,2023
2. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate;Naslund;Clin Ther,2007
3. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial;Abt;Eur Urol,2021
4. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study;Gratzke;BJU Int,2017
5. Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study;McVary;Urology,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献